Brief diagram of the proposed therapeutic effect of the LiESWT in improving detrusor hyperactivity via TRPV channels and the cellular signaling pathway involved in regulating intracellular Ca2+ oscillation in a rat model of OHD-induced DHIC
A brief diagram of the proposed therapeutic effect of the LiESWT in improving detrusor hyperactivity via TRPV channels and the cellular signaling pathway involved in regulating intracellular Ca2+ oscillation in a rat model of OHD-induced DHIC. The OVX-treated rat model was used to mimic the physiological conditions of OHD or the postmenopausal state to induce detrusor hyperactivity symptoms. LiESWT (0.12 mJ/mm2, 300 impulses, 3 Hz) was applied to the lower abdomen of the OHD-induced DHIC rats. Accordingly, the OVX rats had exacerbated pathological damage in the bladder and worse bladder contractile responses, while the LiESWT ameliorated OVX-induced detrusor hyperactivity and improved the bladder contractile function. Additionally, the neurogenesis effect of the LiESWT increased the levels of neurogenesis (NF, NeuN, and GFAP), muscarinic receptors (M2 and M3), purinergic receptor (P2X7), TRPV channels (TRPV1 and TRPV4), ER stress proteins (CHOP, GRP78, and caspase 12), ER-related Ca2+ channels/receptors (RyR, IP3R, and SERCA), and Ano1 that were involved in regulating intracellular Ca2+ oscillation. Meanwhile, the LiESWT treatment significantly enhanced the signaling-pathway-related proteins, including Gq/11, Gq/12, Gq/13, RhoA, and RhoK, in the bladder involved in the activation of ER-related Ca2+ channels/receptors. Therefore, the OVX rats had worse bladder contractile responses that caused bladder contractile deficiency in a rat model of OHD-induced DHIC, while the LiESWT reduced the detrusor hyperactivity and ameliorated the bladder contractile function. The above findings imply that the OHD status after 12 months of OVX resulted in neuronal degeneration and decreased activation of the TRPV1 and TRPV4 channels in a rat model of OHD-induced DHIC. Ach, acetylcholine; DHIC, detrusor hyperactivity with impaired contractility; ER, endoplasmic reticulum; IP3, inositol trisphosphate; IP3R, inositol trisphosphate receptor; LiESWT, low-intensity extracorporeal shock wave therapy; M2/M3, muscarinic receptors; OHD, ovary hormone deficiency; P2X7, purinergic receptor; PKG, protein kinase G; RhoA, ras homolog family member A; RhoK, Rho-associated protein kinase; RyR, ryanodine receptor; SERCA, sarcoplasmic/endoplasmic reticulum Ca-ATPase; TRPV, transient receptor potential vanilloid
Publication
Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates Detrusor Hyperactivity with Impaired Contractility via Transient Potential Vanilloid Channels: A Rat Model for Ovarian Hormone Deficiency (2024) Kuang-Shun Chueh, et al. Int J Mol Sci. 2024 May;25(9). Figure: F8.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | mm2 | MM2 | ncbigene_synonym | PNMA2 | 10687 |
| Homo sapiens | Primates | P2X7 | P2X7 | ncbigene_synonym | P2RX7 | 5027 |
| Homo sapiens | Primates | Ach | ACH | ncbigene_synonym | FGFR3 | 2261 |
| Homo sapiens | Primates | PKG | PKG | ncbigene_synonym | PRKG1 | 5592 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A1 | 487 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A2 | 488 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A3 | 489 |
| Homo sapiens | Primates | Gq/11 | GQ | famplex_relations | GNAQ | 2776 |
| Homo sapiens | Primates | Gq/11 | GQ | famplex_relations | GNA11 | 2767 |
| Homo sapiens | Primates | Gq/11 | GQ | famplex_relations | GNA14 | 9630 |
| Homo sapiens | Primates | Gq/11 | GQ | famplex_relations | GNA15 | 2769 |
| Homo sapiens | Primates | TRPV1 | TRPV1 | ncbigene_symbol | TRPV1 | 7442 |
| Homo sapiens | Primates | TRPV4 | TRPV4 | ncbigene_symbol | TRPV4 | 59341 |
| Homo sapiens | Primates | PLC | PLC | ncbigene_synonym | HSPG2 | 3339 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCE1 | 51196 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCZ1 | 89869 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCB1 | 23236 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCB2 | 5330 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCB3 | 5331 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCB4 | 5332 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCD1 | 5333 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCD3 | 113026 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCD4 | 84812 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCG1 | 5335 |
| Homo sapiens | Primates | PLC | PLC | famplex_relations | PLCG2 | 5336 |
| Homo sapiens | Primates | IP3R | IP3R | ncbigene_synonym | ITPR1 | 3708 |
| Homo sapiens | Primates | IP3R | IP3R | ncbigene_synonym | ITPR3 | 3710 |
| Homo sapiens | Primates | RyR | RYR | ncbigene_synonym | RYR1 | 6261 |
| Homo sapiens | Primates | RyR | RYR | ncbigene_synonym | RYR2 | 6262 |
| Homo sapiens | Primates | RyR | RYR | famplex_relations | RYR3 | 6263 |
| Homo sapiens | Primates | Gap | GAP | ncbigene_synonym | RASA1 | 5921 |
| Homo sapiens | Primates | Gap | GAP | ncbigene_synonym | RGS6 | 9628 |
| Homo sapiens | Primates | G12 | G12 | famplex_relations | GNA12 | 2768 |
| Homo sapiens | Primates | G12 | G12 | famplex_relations | GNA13 | 10672 |
| Homo sapiens | Primates | G12/13 | G13 | ncbigene_synonym | ATF6B | 1388 |
| Homo sapiens | Primates | RhoA | RHOA | ncbigene_symbol | RHOA | 387 |
| Homo sapiens | Primates | Rhok | RHOK | ncbigene_synonym | GRK1 | 6011 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Ca2+ | Ca2+ | Ca(2+) | chebi:29108 | |
| Nucleus | nucleus | nucleus | chebi:33252 | |
| Ca2+ | Ca2+ | Ca(2+) | chebi:29108 | |
| Ach | ACh | 2-acetyloxy-N,N,N-trimethylethanaminium | chebi:15355 | |
| SERCA | SerCA | L-serocholate | chebi:229711 | |
| Ach | ACh | 2-acetyloxy-N,N,N-trimethylethanaminium | chebi:15355 | |
| Nucleus | nucleus | nucleus | chebi:33252 | |
| Ca2+ | Ca2+ | Ca(2+) | chebi:29108 | |
| Ach | ACh | 2-acetyloxy-N,N,N-trimethylethanaminium | chebi:15355 | |
| Nucleus | nucleus | nucleus | chebi:33252 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|